Discovery of potential epidermal growth factor receptor inhibitors from black pepper for the treatment of lung cancer: an in-silico approach

Olusola Olalekan Elekofehinti1, Ifeoluwa Rachael Adetoyi1, Hannah Oluwaseun Popoola2, Folasade Oluwatobiloba Ayodeji1, Foluso Adeola Taiwo1, Moses Orimoloye Akinjiyan1, Omowunmi Funmilayo Koledoye2, Opeyemi Iwaloye1, Abayomi Emmanuel Adegboyega3
1Bioinformatics and Molecular Biology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State, Nigeria
2Phytomedicine Biochemical Pharmacology and Toxicology Unit, Department of Biochemistry, Federal University of Technology Akure, Akure, Ondo State, Nigeria
3Department of Biochemistry, Faculty of Basic Medical Sciences, University of Jos, Jos, Plateau State, Nigeria

Tóm tắt

Từ khóa


Tài liệu tham khảo

Acharya SG, Momin AH, Gajjar AV (2012) Review of piperine as a bio-enhancer. Amer J PharmTech Res 2:32–44

Ahmad N, Fazal H, Abbasi B, Farooq S, Ali M, Khan M (2012a) Biological role of Piper nigrum L. (Black pepper): a review. Asian Pac J Trop Biomed 2(3):S1945

Ahmad N, Fazal H, Abbasi BH, Farooq S, Ali M et al (2012) Biological role of Piper nigrum L. (Black pepper): A review. Asian Pacific Journal of Tropical Biomedicine: S1945-S1953

Beniston M (2011) ‘Alps’, Encyclopedia of Earth Sciences Series, Part 3, 35–38, doi: https://doi.org/10.1007/978-90-481-2642-2_16

Carcereny E, Morán T, Capdevila L, Cros S, Vilà L et al (2015) The epidermal growth factor receptor (EGRF) in lung cancer. Trans Respir Med 3(1):1. https://doi.org/10.1186/s40247-015-0013-z

Schrödinger Release 2018–2: Maestro, Schrödinger, LLC, New York, NY, 2018.

Cruz CS, Tanoue LT, Matthay RA (2011) Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 32(4):605–644. https://doi.org/10.1016/j.ccm.2011.09.001

Daina A, Michielin O, Zoete V et al (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7(1):42717

de Oliveira MT, Katekawa E (2017) On the virtues of automated QSAR—the new kid on the block. Future Med Chem. https://doi.org/10.4155/FMC-2017-0170

Dixon SL, Duan J, Smith E, Von Bargen CD, Sherman W, Repasky MP (2016) AutoQSAR: an automated machine learning tool for best-practice QSAR modeling. Future Med Chem 8:1825–1839

Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449–461

Hadni H, Elhallaoui M (2020) 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents. Heliyon 6(4):e03580

Haq IU, Imran M, Nadeem M, Tufail T, Gondal TA, Mubarak MS (2021) Piperine: A review of its biological effects. Phytother Res 35(2):680–700

Inamura K, Ninomiya H, Ishikawa Y, Matsubara O (2010) Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? Arch Pathol Lab Med 134:66–72

Iwaloye O, Elekofehinti OO, Oluwarotimi EA, Babatomiwa K, Momoh I (2020) Insilico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design. Netw Model Anal Health Inform Bioinform 9:54

Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH et al (2011) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 55:1169–1176

Maione P, Sacco PC, Sgambato A, Casaluce F, Rossi A, Gridelli C (2015) Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application. Ther Adv Med Oncol 7(5):263–273

Miller VA, Hirsh V, Cadranel J, Chen YM, Park K, Kim SW, Zhou C, Su WC, Wang M, Sun Y, Heo DS, Crino L, Tan EH, Chao TY, Shahidi M, Cong XJ, Lorence RM, Yang JC (2012) Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol 13(5):528–538. https://doi.org/10.1016/S1470-2045(12)70087-6

Nandi S, Bagchi MC (2010) 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: A rational approach to anticancer drug design. Mol Diversity 14:27–38

Nandi S, Bagchi MC (2011) In silico design of potent EGFR kinase inhibitors by structure-based screening of combinatorial libraries. Mol Simul 37:196–209

Nandi S, Bagchi MC (2016) EGFr, FGFr and PDGFr: emerging targets for anticancer drug design. J Cancer Res 5:99–108

Nandi S, Dey R, Samadder A, Saxena AK (2022a) Natural sourced inhibitors of EGFR, PDGFR, FGFR and VEGFR-mediated signaling pathways as potential anticancer agents. Curr Med Chem 29(2):212–234

Nandi S, Dey R, Dey S, Samadder A, Saxena AK (2022b) Naturally sourced CDK inhibitors and current trends in structure-based synthetic anticancer drug design by crystallography. Anticancer Agents Med Chem 22(3):485–498

Paarakh PM, Sreeram DC (2015) In vitro cytotoxic and in silico activity of piperine isolated from Piper nigrum fruits Linn. In Silico Pharmacology 3(1):9. https://doi.org/10.1186/s40203-015-0013-2

Parganiha R, Verma S, Chandrakar S, Pal S, Sawarkar HA, Kashyap P (2011) In vitro anti- asthmatic activity of fruit extract of Piper nigrum (Piperaceae). Int J Herbs Pharmacol Res 1:15–18

Sastry M, Lowrie JF, Dixon SL, Sherman W (2010) Large-scale systematic analysis of 2D fingerprint methods and parameters to improve virtual screening enrichments. J Chem Inf Model 50:771–784

Schrank Z, Chhabra G, Lin L, Iderzorig T, Osude C, Khan N, Kuckovic A, Singh S, Miller RJ, Puri N (2018) Current molecular-targeted therapies in NSCLC and their mechanism of resistance. Cancers 10(7):224

Schrödinger Release 201 8–4: LigPrep (2018) Schrödinger. LLC, New York, NY. 2018

Schrödinger Release 2020–2: Induced Fit Docking protocol; Glide, Schrödinger, LLC, New York, NY (2016) Prime, Schrödinger, LLC, New York, NY, 2020

Schrödinger Release 2020–2: Prime, Schrödinger. New York, NY: LLC, 2020.

Sitki-Copur M (2019) State of cancer research around the globe. Oncol J 33(5):181–185

Schrödinger Suite (2012) Protein Preparation Wizard; Epik version 2.3, Schrödinger, LLC, New York, NY, 2012; Impact version 5.8, Schrödinger, LLC, New York, NY, 2012; Prime version 3.1, Schrödinger, LLC, New York, NY, 2012.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249

Vijayakumar S, Manogar P, Prabhu S, Singh RAS (2018) Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer’s disease. J Pharm Anal 8:413–420

Yun CH, Boggon TJ, Li Y, Woo S, Greulich H, Meyerson M, Eck MJ (2007) Structures of lung cancer-derived Egfr mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell 11:217